{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:51:49Z","timestamp":1794185509101,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ophtha.2026.06.023","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:24:53Z","timestamp":1782861893000},"page":"1349-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-7768","authenticated-orcid":false,"given":"Justis P.","family":"Ehlers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-4957","authenticated-orcid":false,"given":"Hasan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3803-4228","authenticated-orcid":false,"given":"Reem","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-6487","authenticated-orcid":false,"given":"Karen","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Indurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Della Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8243-9319","authenticated-orcid":false,"given":"Dina Joy K.","family":"Abulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.oret.2020.11.003","article-title":"Relationship of topographic distribution of geographic atrophy to visual acuity in nonexudative age-related macular degeneration","volume":"5","author":"Shen","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ophtha.2026.06.023_bib2","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ophtha.2026.06.023_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000517520","article-title":"Age-related macular degeneration: pathophysiology, management, and future perspectives","volume":"244","author":"Flores","year":"2021","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2024.07.025","article-title":"The discrepancy between visual acuity decline and foveal involvement in geographic atrophy","volume":"9","author":"Cicinelli","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.ophtha.2026.06.023_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamaophthalmol.2021.1407","article-title":"Enlargement of geographic atrophy from first diagnosis to end of life","volume":"139","author":"Colijn","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.06.023_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40123-021-00352-3","article-title":"Seeing beyond anatomy: quality of life with geographic atrophy","volume":"10","author":"Caswell","year":"2021","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"10.1016\/j.ophtha.2026.06.023_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2026.06.023_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","article-title":"The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence-based OCT analysis","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2026.06.023_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajo.2022.06.023","article-title":"Comparison of fundus autofluorescence versus optical coherence tomography-based evaluation of the therapeutic response to pegcetacoplan in geographic atrophy","volume":"244","author":"Mai","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.06.023_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/IAE.0000000000001946","article-title":"Optical coherence tomography and histology of age-related macular degeneration support mitochondria as reflectivity sources","volume":"38","author":"Litts","year":"2018","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ophtha.2026.06.023_bib11","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.12.27","article-title":"Challenges associated with ellipsoid zone intensity measurements using optical coherence tomography","volume":"10","author":"Lee","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"22","key":"10.1016\/j.ophtha.2026.06.023_bib12","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1242\/jcs.175687","article-title":"Photoreceptors at a glance","volume":"128","author":"Molday","year":"2015","journal-title":"J Cell Sci"},{"issue":"5","key":"10.1016\/j.ophtha.2026.06.023_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ceo.12685","article-title":"Ellipsoid zone on optical coherence tomography: a review","volume":"44","author":"Tao","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2026.06.023_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14050543","article-title":"Ellipsoid zone integrity and visual function in dry age-related macular degeneration","volume":"14","author":"Yordi","year":"2024","journal-title":"J Pers Med"},{"issue":"10","key":"10.1016\/j.ophtha.2026.06.023_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamaophthalmol.2020.2914","article-title":"Progression of photoreceptor degeneration in geographic atrophy secondary to age-related macular degeneration","volume":"138","author":"Pfau","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.06.023_bib16","article-title":"A closer look at ellipsoid zone attenuation","author":"Ehlers","year":"2024","journal-title":"Retina Today"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100628","article-title":"ReCLAIM-2: a randomized phase II clinical trial evaluating elamipretide in age-related macular degeneration, geographic atrophy growth, visual function, and ellipsoid zone preservation","volume":"5","author":"Ehlers","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"10","key":"10.1016\/j.ophtha.2026.06.023_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203324","article-title":"Assessment of inner and outer retinal layer metrics on the Cirrus HD-OCT platform in normal eyes","volume":"13","author":"Arepalli","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3928\/23258160-20211210-01","article-title":"Risk classification for progression to subfoveal geographic atrophy in dry age-related macular degeneration using machine learning-enabled outer retinal feature extraction","volume":"53","author":"Sarici","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"10.1016\/j.ophtha.2026.06.023_bib20","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.9.24","article-title":"Clinical correlation between optical coherence tomography biomarkers and retinal sensitivity in best vitelliform macular dystrophy","volume":"11","author":"Battaglia Parodi","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.06.023_bib21","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.3.31","article-title":"Ellipsoid zone defects in retinal vein occlusion correlates with visual acuity prognosis: SCORE2 report 14","volume":"10","author":"Etheridge","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.06.023_bib22","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1111\/aos.14542","article-title":"Ellipsoid zone optical intensity reduction as an early biomarker for retinitis pigmentosa","volume":"99","author":"Gong","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2026.06.023_bib23","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1111\/aos.14110","article-title":"Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2","volume":"97","author":"Pauleikhoff","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib24","article-title":"Baseline characterization of advanced ellipsoid zone integrity features in the GATHER1 phase 2\/3 clinical trial for AMD with geographic atrophy","volume":"64","author":"Amine","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ophtha.2026.06.023_bib25","first-page":"1769","article-title":"Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography","volume":"103","author":"Roh","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.06.023_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/tjo.tjo_29_22","article-title":"Does outer retinal layer thickness correlate with the central visual field indices in early dry age-related macular degeneration?","volume":"12","author":"Acharya","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2026.06.023_bib27","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1097\/IAE.0000000000002717","article-title":"Topographic analysis of photoreceptor loss correlated with disease morphology in neovascular age-related macular degeneration","volume":"40","author":"Riedl","year":"2020","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.oret.2024.02.010","article-title":"Compartmental exudative dynamics in neovascular age-related macular degeneration: volumetric outcomes and impact of volatility in a phase III clinical trial","volume":"8","author":"Ehlers","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib29","article-title":"Impact of baseline quantitative ellipsoid zone integrity on geographic atrophy expansion in the ReCLAIM-2 clinical trial","volume":"64","author":"Whitmore","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib30","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/IAE.0000000000001824","article-title":"Classification and quantitative analysis of geographic atrophy junctional zone using spectral domain optical coherence tomography","volume":"38","author":"Qu","year":"2018","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ophtha.2026.06.023_bib31","article-title":"Characterization of baseline \u201cEZ at-risk\u201d burden using deep learning feature extraction in the GATHER1 phase 2\/3 clinical trial","volume":"64","author":"Yordi","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2026.06.023_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.oret.2020.12.009","article-title":"Imaging features associated with progression to geographic atrophy in age-related macular degeneration: Classification of Atrophy Meeting report 5","volume":"5","author":"Jaffe","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"10411","key":"10.1016\/j.ophtha.2026.06.023_bib33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"10.1016\/j.ophtha.2026.06.023_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ophtha.2026.06.023_bib35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2026.06.023_bib36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.06.023_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100213","article-title":"A clinical and preclinical assessment of clinical trials for dry age-related macular degeneration","volume":"2","author":"Abidi","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ophtha.2026.06.023_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100893","article-title":"Fundus autofluorescence imaging","volume":"81","author":"Schmitz-Valckenberg","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"10.1016\/j.ophtha.2026.06.023_bib39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the Chroma and Spectri phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"10.1016\/j.ophtha.2026.06.023_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ophtha.2024.11.017","article-title":"Visual loss in geographic atrophy: learnings from the lampalizumab trials","volume":"132","author":"Anegondi","year":"2025","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40123-022-00583-y","article-title":"Dry age-related macular degeneration: distribution of visual acuity and progression risk in a large registry","volume":"12","author":"Leng","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ophtha.2026.06.023_bib42","article-title":"IZERVAY package insert","year":"2025"},{"issue":"4","key":"10.1016\/j.ophtha.2026.06.023_bib43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"issue":"17","key":"10.1016\/j.ophtha.2026.06.023_bib44","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye (Lond)"},{"issue":"21","key":"10.1016\/j.ophtha.2026.06.023_bib45","article-title":"Validation of inter-reader agreement\/consistency for quantification of ellipsoid zone integrity and sub-RPE compartmental features across retinal diseases","volume":"14","author":"Bell","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ophtha.2026.06.023_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajo.2024.04.031","article-title":"Correlation between blue fundus autofluorescence and SD-OCT measurements of geographic atrophy in dry age-related macular degeneration","volume":"266","author":"Ehlers","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.06.023_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bjophthalmol-2015-307105","article-title":"Volumetric ellipsoid zone mapping for enhanced visualisation of outer retinal integrity with optical coherence tomography","volume":"100","author":"Itoh","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib48","article-title":"Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy","volume":"8","author":"Katschke","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ophtha.2026.06.023_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2016.03.001","article-title":"Targeting the complement system for the management of retinal inflammatory and degenerative diseases","volume":"787","author":"Xu","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ophtha.2026.06.023_bib50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ophtha.2026.06.023_bib51","series-title":"Syfovre\u00ae package insert","year":"2024"},{"issue":"2","key":"10.1016\/j.ophtha.2026.06.023_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2024.08.017","article-title":"Disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT","volume":"132","author":"Schmidt-Erfurth","year":"2025","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2026.06.023_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00735-7","article-title":"Ellipsoid zone reflectivity as a functional imaging biomarker for age-related macular degeneration: a MACUSTAR study report","volume":"15","author":"Liermann","year":"2025","journal-title":"Sci Rep"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:56:42Z","timestamp":1792483002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0161642026004574"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.06.023","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}